Unlike that of 3T3-L1, glioblastoma, and prostate cancer cells, the contribution of GRβ to the regulation of factors involved in the skeletal muscle myogenic program, such as MyoD and myogenin, remains to be determined. The gene discussed is GZMB; the disease is prostate carcinoma.